Air-in-line alarms during IV cancer drug infusion
This study looks at how often air-in-line alarms go off during IV cancer drug infusions, to help improve patient safety. If you are a nurse or doctor who gives IV chemotherapy and work at a participating site, you could take part.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthcare professional such as a nurse or doctor who gives cancer drugs through an IV
- You work at one of the hospitals or clinics taking part in the study
- You regularly give IV cancer treatments as part of your usual job
- You are okay with having your infusion procedures watched for the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a device or method to make IV infusions safer for patients who need fluids or medications through a tube in a vein. It's for adults who already have or will get an IV line for treatments lasting at least 15 minutes.
This study tests a set of best practices to help nurses and anesthesiologists manage IV lines more safely, which may reduce infections and other complications.
This study uses a smart care system during radiation therapy to monitor your blood in real time and help keep you safe. It also aims to reduce treatment-related anxiety by giving you and your care team better support.
This study asks young adults (ages 18–39) receiving cancer care in an infusion clinic to share their experience through a satisfaction survey. It’s meant to understand what helps patients during infusion visits so care can be improved.
This study tests a monitoring system that checks for signs of vein irritation or fluid leaking around the IV site. It may help catch problems early and improve comfort during treatment.
This trial studies whether a simple “remote conditioning” treatment on the arm can help protect the heart while you receive chemotherapy that includes anthracyclines. If you’re at higher risk for heart damage from chemo, this may reduce risk and help monitor heart function over time.
Hear when a new Medication Safety trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.